The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice
- PMID: 1659596
- DOI: 10.1093/infdis/164.6.1091
The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice
Abstract
The pathogenicity of ribonucleotide reductase (RR)-null mutants (hrR3 and ICP6 delta) of herpes simplex virus (HSV) type 1 was studied after intracerebral and corneal inoculation in newborn and adult ICR mice. ICP6 delta failed to replicate in brains of mice greater than or equal to 8 days old but exhibited significant virulence for newborn mice as a result of viral replication in the brains. The RR- and a thymidine kinase (TK)-deficient mutant of HSV-1 strain KOS could grow in eye tissues of adult ICR mice. Viral DNA of hrR3 was detected in brain tissues of intracerebrally infected mice or in the trigeminal ganglia of corneally infected mice greater than or equal to 50 days after infection, and infectious hrR3 could be recovered from these tissues by superinfection of the mice with wild-type HSV-2. These observations indicate that pathogenicity of RR- mutants in mice is highly dependent on the physiologic state of tissues infected and that RR- mutants have the ability to establish latency in nervous system tissues of mice by either the peripheral or intracerebral route. It was also demonstrated that the inability of the RR- mutants to invade the central nervous system was efficiently complemented by simultaneous infection with another defective virus, the TK- mutant of KOS.
Similar articles
-
The herpes simplex virus ribonucleotide reductase is required for ocular virulence.J Gen Virol. 1991 Sep;72 ( Pt 9):2043-9. doi: 10.1099/0022-1317-72-9-2043. J Gen Virol. 1991. PMID: 1654368
-
Deletion of the herpes simplex virus type 1 ribonucleotide reductase gene alters virulence and latency in vivo.Antiviral Res. 1992 Feb;17(2):145-56. doi: 10.1016/0166-3542(92)90048-a. Antiviral Res. 1992. PMID: 1313220
-
Quantitative polymerase chain reaction analysis of herpes simplex virus DNA in ganglia of mice infected with replication-incompetent mutants.J Virol. 1990 Sep;64(9):4288-95. doi: 10.1128/JVI.64.9.4288-4295.1990. J Virol. 1990. PMID: 2166818 Free PMC article.
-
A low thymidine kinase-producing mutant of herpes simplex virus type 1 causes latent trigeminal ganglia infections in mice.Arch Virol. 1983;76(1):39-49. doi: 10.1007/BF01315702. Arch Virol. 1983. PMID: 6305312
-
Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo.J Exp Med. 1999 Feb 15;189(4):663-72. doi: 10.1084/jem.189.4.663. J Exp Med. 1999. PMID: 9989981 Free PMC article.
Cited by
-
Sequences of the ribonucleotide reductase-encoding genes of felid herpesvirus 1 and molecular phylogenetic analysis.Virus Genes. 1997;15(3):203-18. doi: 10.1023/a:1007924419113. Virus Genes. 1997. PMID: 9482586
-
Evaluation of a peptidomimetic ribonucleotide reductase inhibitor with a murine model of herpes simplex virus type 1 ocular disease.Antimicrob Agents Chemother. 1996 May;40(5):1078-84. doi: 10.1128/AAC.40.5.1078. Antimicrob Agents Chemother. 1996. PMID: 8723444 Free PMC article.
-
Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates.J Virol. 1999 Aug;73(8):6319-26. doi: 10.1128/JVI.73.8.6319-6326.1999. J Virol. 1999. PMID: 10400723 Free PMC article.
-
The range and distribution of murine central nervous system cells infected with the gamma(1)34.5- mutant of herpes simplex virus 1.J Virol. 1997 Jul;71(7):5560-9. doi: 10.1128/JVI.71.7.5560-5569.1997. J Virol. 1997. PMID: 9188630 Free PMC article.
-
Shedding the Light on Litopenaeus vannamei Differential Muscle and Hepatopancreas Immune Responses in White Spot Syndrome Virus (WSSV) Exposure.Genes (Basel). 2020 Jul 16;11(7):805. doi: 10.3390/genes11070805. Genes (Basel). 2020. PMID: 32708590 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical